Development of recombinant chimeric antigen expressing immunodominant B epitopes of Leishmania infantum for serodiagnosis of visceral leishmaniasis

Clinical and Diagnostic Laboratory Immunology

Volumn 12, Issue 5, 2005, Pages 647-653

  Boarino, A ^a   Scalone, A ^b   Gradoni, L ^b   Ferroglio, E ^a   Vitale, F ^c   Zanatta, R ^a   Giuffrida, M G ^d   Rosati, S ^a,e  

^a UNIVERSITY OF TURIN   (Italy)

^b ISTITUTO SUPERIORE DI SANITÀ   (Italy)

^c ISTITUTO ZOOPROFILATTICO SPERIMENTALE DELLA SICILIA A MIRRI   (Italy)

^d CNR   (Italy)

^e Facolta di Medicina Veterinaria   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIBODY; ANTIGEN; EPITOPE; K26 ANTIGEN; K39SUB ANTIGEN; K9 ANTIGEN; KINESIN; RECOMBINANT ANTIGEN; UNCLASSIFIED DRUG;

AFFINITY CHROMATOGRAPHY; ARTICLE; CANIDAE; CONTROLLED STUDY; DOG; ENZYME LINKED IMMUNOSORBENT ASSAY; ESCHERICHIA COLI; HUMAN; IMMUNOASSAY; IMMUNOFLUORESCENCE TEST; IMMUNOREACTIVITY; LEISHMANIA INFANTUM; MAJOR CLINICAL STUDY; NONHUMAN; NUCLEOTIDE SEQUENCE; OPEN READING FRAME; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; SENSITIVITY AND SPECIFICITY; SERODIAGNOSIS; VISCERAL LEISHMANIASIS; ZOONOSIS;

ADULT; ANIMALS; ANTIGENS, PROTOZOAN; DOG DISEASES; DOGS; ENZYME-LINKED IMMUNOSORBENT ASSAY; FEMALE; HUMANS; IMMUNODOMINANT EPITOPES; LEISHMANIA INFANTUM; LEISHMANIASIS, VISCERAL; MALE; MIDDLE AGED; PROTOZOAN PROTEINS; RECOMBINANT FUSION PROTEINS; SEROLOGIC TESTS; SPECIES SPECIFICITY;

EID: 23944522807     PISSN: 1071412X     EISSN: None     Source Type: Journal    
DOI: 10.1128/CDLI.12.5.647-653.2005     Document Type: Article

References (41)

1. Altintas, N., A. Yolasigmaz, N. Sakru, S. Yazar, S. Ertug, and Y. Ozbel. 1998. A sero-epidemiological study of visceral leishmaniosis in Izmir District, Turkey. J. Egypt. Soc. Parasitol. 28:389-394.
2. Alvar, J., B. Gutierrez-Solar, I. Pachon, E. Calbacho, M. Ramirez, R. Valles, J. L. Guillen, C. Canavate, and C. Amela. 1996. AIDS and Leishmania infantum. New approaches for a new epidemiological problem. Clin. Dermatol. 14:541-546.
3. Ashford, R. W. 2000. The leishmaniases as emerging and reemerging zoonoses. Int. J. Parasitol. 30:1269-1281.
4. Badarò, R., D. Benson, M. C. Eulalio, M. Freire, S. Cunha, E. M. Netto, D. Pedral-Sampaio, C. Madureira, J. M. Burns, R. L. Houghton, J. R. David, and S. G. Reed. 1996. rK39: a cloned antigen of Leishmania chagasi that predicts active visceral leishmaniasis. J. Infect. Dis. 173:758-761.
5. Bhatia, A., N. S. Daifalla, S. Jen, R. Badarò, S. G. Reed, and Y. A. Skeiky. 1999. Cloning, characterization and serological evaluation of K9 and K26: two related hydrophilic antigens of Leishmania chagasi. Mol. Biochem. Parasitol. 102:249-261.
6. Bradford, M. M. 1976. A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye binding. Anal. Biochem. 72:248-254.
7. Braz, R. F., E. T. Nascimento, D. R. Martins, M. E. Wilson, R. D. Pearson, S. G. Reed, and S. M. Jeronimo. 2002. The sensitivity and specificity of Leishmania chagasi recombinant K39 antigen in the diagnosis of American visceral leishmaniasis and in differentiating active from subclinical infection. Am. J. Trop. Med. Hyg. 67:344-348.
8. Burns, J. M., Jr., W. G. Shreffler, D. R. Benson, H. W. Ghalib, R. Badarò, and S. G. Reed. 1993. Molecular characterization of a kinesin-related antigen of Leishmania chagasi that detects specific antibody in African and American visceral leishmaniasis. Proc. Natl. Acad. Sci. USA 90:775-779.
9. Desjeux, P. 1996. Leishmaniasis. Public health aspects and control. Clin. Dermatol. 14:417-423.
10. Desjeux, P. 1999. Global control and Leishmania HIV co-infection. Clin. Dermatol. 17:317-325.
11. Desjeux, P. 2001. The increase in risk factors for leishmaniasis worldwide. Trans. R. Soc. Trop. Med. Hyg. 95:239-243.
12. Dye, C. 1996. The logic of visceral leishmaniasis control. Am. J. Trop. Med. Hyg. 55:125-130.
13. Dye, C., E. Vidor, and J. Deneure. 1993. Serological diagnosis of leishmaniasis: on detecting infection as well as disease. Epidemiol. Infect. 103:647-656.
14. Ferroglio, E., M. Maroli, W. Mignone, S. Gastaldo, C. Raimondo, A. Trisciuoglio, and L. Rossi. 2002. Endemic canine leishmaniasis foci in North-West Italy. Environ. Risques Santé 1:47-49.
15. Gradoni, L., A. Scalone, M. Gramiccia, and M. Troiani. 1996. Epidemiological surveillance of leishmaniasis in HIV-1-infected individuals in Italy. AIDS 10:785-791.
16. Gradoni, L., and M. Gramiccia. 2000. Leishmaniasis, p. 803-812. In OIE (ed.), Manual of standards for diagnostic tests and vaccines. Office International des Epizooties (OIE), Paris, France.
17. Houghton, R. L., M. Petrescu, D. R. Benson, Y. A. Skeiky, A. Scalone, R. Badarò, S. G. Reed, and L. Gradoni. 1998. A cloned antigen (recombinant K39) of Leishmania chagasi diagnostic for visceral leishmaniasis in human immunodeficiency virus type 1 patients and a prognostic indicator for monitoring patients undergoing drug therapy. J. Infect. Dis. 177:1339-1344.
18. Ibrahim, M. E., B. Lambson, A. O. Yousif, N. S. Deifalla, D. A. Alnaiem, A. Ismail, H. Yousif, H. W. Ghalib, E. A. Khalil, A. Kadaro, D. C. Barker, and A. M. El Hassan. 1999. Kala-azar in a high transmission focus: an ethnic and geographic dimension Am. J. Trop. Med. Hyg. 61:941-944.
19. Ihaka, R., and R. Gentleman. 1996. R: a language for data analysis and graphics. J. Comput. Graph. Stat. 5:299-314.
20. Jensen, A. T., S. Gasim, T. Moller, A. Ismail, A. Gaafar, M. Kemp, A. M. el Hassan, A. Kharazmi, T. G. Theander, and K. Andersen. 1999. Serodiagnosis of Leishmania donovani infections: assessment of enzyme-linked immunosorbent assays using recombinant L. donovani gene B protein (GBP) and a peptide sequence of L. donovani GBP. Trans. R. Soc. Trop. Med. Hyg. 93:157-160.
21. Kumar, R., K. Pai, K. Pathak, and S. Sundar. 2001. Enzyme-linked immunosorbent assay for recombinant K39 antigen in diagnosis and prognosis of Indian visceral leishmaniasis. Clin. Diagn. Lab. Immunol. 8:1220-1224.
22. Maalej, I. A., M. Chenik, H. Louzir, S. A. Ben Salah, C. Bahloul, F. Amri, and K. Dellagi. 2003. Comparative evaluation of ELISAs based on ten recombinant or purified Leishmania antigens for the serodiagnosis of Mediterranean visceral leishmaniasis. Am. J. Trop. Med. Hyg. 68:312-320.
23. Martin, S. K., L. Thuita-Harun, M. Adoyo-Adoyo, and K. M. Wasunna. 1998. A diagnostic ELISA for visceral leishmaniasis, based on antigen from media conditioned by Leishmania donovani promastigotes. Ann. Trop. Med. Parasitol. 92:571-577.
24. Maurício, L. L., J. R. Stothard, and M. A. Miles. 2000. The strange case of Leishmania chagasi. Parasitol. Today 16:188-189.
25. Moreno, J., and J. Alvar. 2002. Canine leishmaniasis: epidemiological risk and the experimental model. Trends Parasitol. 18:399-405.
26. Ozbel, Y., N. Turgay, S. Ozensoy, A. Ozbilgin, M. Z. Alkan, M. A. Ozcel, C. L. Jaffe, L. Schnur, L. Oskam, and P. Abranches. 1995. Epidemiology, diagnosis and control of leishmaniasis in the Mediterranean region. Ann. Trop. Med. Parasitol. 89:89-93.
27. Ozensoy, S., Y. Ozbel, N. Turgay, M. Z. Alkan, K. Gul, A. Gilman-Sachs, K. P. Chang, S. G. Reed, and M. A, Ozcel. 1998. Serodiagnosis and epidemiology of visceral leishmaniasis in Turkey. Am. J. Trop. Med. Hyg. 59:363-369.
28. Qu, J. Q., L. Zhong, M. Masoom-Yasinzai, M. Abdur-Rab, H. S. Aksu, S. G. Reed, K. P. Chang, and A. Gilman-Sachs. 1994. Serodiagnosis of Asian leishmaniasis with a recombinant antigen from the repetitive domain of a Leishmania kinesin. Trans. R. Soc. Trop. Med. Hyg. 88:543-545.
29. Raj, V. S., A. Ghosh, V. S. Dole, R. Madhubala, P. J. Myler, and K. D. Stuart. 1999. Serodiagnosis of leishmaniasis with recombinant ORFF antigen. Am. J. Trop. Med. Hyg. 61:482-487.
30. Rajasekariah, G. H., J. R. Ryan, S. R. Millier, L. P. Yi, J. M. Stiteler, L. Cui, A. M. Smithyman, and S. K. Martin. 2001. Optimisation of an ELISA for the serodiagnosis of visceral leishmaniasis using in vitro derived promastigote antigens. J. Immunol. Methods 252:105-119.
31. Reed, S. G. 1996. Diagnosis of Leishmaniasis. Clin. Dermatol. 14:471-478.
32. Reithinger, R., and C. R. Davies. 2002. Canine leishmaniasis: novel strategies for control. Trends Parasitol. 18:289-290.
33. Rhalem, A., H. Sahibi, N. Guessous-Idrissi, S. Lasri, A. Natami, M. Riyad, and B. Berrag. 1999. Immune response against Leishmania antigens in dogs naturally and experimentally infected with Leishmania infantum. Vet. Parasitol. 81:173-184.
34. Rosati, S., M. Ortoffi, M. Profiti, A. Mannelli, W. Mignone, E. Bollo, and L. Gradoni. 2003. Prokaryotic expression and antigenic characterization of three recombinant Leishmania antigens for serological diagnosis of canine leishmaniasis. Clin. Diagn. Lab. Immunol. 10:1153-1156.
35. Scalone, A., R. De Luna, G. Oliva, L. Baldi, G. Satta, G. Vesco, W. Mignone, C. Turilli, R. R. Mondesire, D. Simpson, A. R. Donoghue, G. R. Frank, and L. Gradoni. 2002. Evaluation of the Leishmania recombinant K39 antigen as a diagnostic marker for canine leishmaniasis and validation of a standardized enzyme-linked immunosorbent assay. Vet. Parasitol. 104:275-285.
36. Singh, S., A. Gilman-Sachs, K. P. Chang, and S. G. Reed. 1995. Diagnostic and prognostic value of K39 recombinant antigen in Indian leishmaniasis. J. Parasitol. 81:1000-1003.
37. Soto, M., J. M. Requena, L. Quijada, and C. Alonso. 1998. Multicomponent chimeric antigen for serodiagnosis of canine visceral leishmaniasis. J. Clin. Microbiol. 36:58-63.
38. Sundar, S., and M. Rai. 2002. Laboratory diagnosis of visceral leishmaniaisis. Clin. Diagn. Lab. Immunol. 9:951-958.
39. Tesh, R. B. 1995. Control of zoonotic visceral leishmaniasis: is it time to change strategies? Am. J. Trop. Med. Hyg. 52:287-292.
40. Zerpa, O., M. Ulrich, E. Negron, N. Rodriguez, M. Centeno, V. Rodriguez, R. M. Barrios, D. Belizario, S. Reed, and J. Convit. 2000. Canine visceral leishmaniasis on Margarita Island (Nueva Esparta. Venezuela). Trans. R. Soc. Trop. Med. Hyg. 94:484-487.
41. Zijlstra, E. E., N. S. Daifalla, P. A. Kager, E. A. Khalil, A. M. El-Hassan, S. G. Reed, and H. W. Ghalib. 1998. rK39 enzyme-linked immunosorbent assay for diagnosis of Leishmania donovani infection. Clin. Diagn. Lab. Immunol. 5:717-720.